New Treatment For Sickle Cell Disease: 2025 Pipeline Highlights - Data Intelligence
5 Articles
5 Articles
Special Report: Genotype and blood group compatibility
Genotype compatibility helps reduce the risk of Sickle Cell Disease in future generations. Blood group awareness is vital for safe transfusions and maternal health outcomes. Young people and their families are encouraged to prioritize medical screening in relationships. In today’s world where emotions often take precedence in choosing life partners, health experts are urging individuals,especially […] The post Special Report: Genotype and blood …
New Treatment For Sickle Cell Disease: 2025 Pipeline Highlights - Data Intelligence
Newsletter Signup – Under Article / In Page “*” indicates required fields For people living with sickle cell disease, it means facing lifelong challenges marked by episodes of severe pain, fatigue, and frequent medical visits. This is because the inherited blood disorder, which is characterized by an abnormality in the protein hemoglobin, disrupts the normal function of red blood cells, causing them to become hard, sticky, and C-shaped, like a ‘…
Intranasal fentanyl offers fast pain relief for adults with SCD: Study
Fentanyl may be a feasible, safe, and effective option when administered intranasally (into the nose), to manage acute moderate to severe pain episodes in adults with sickle cell disease (SCD), a study in Canada reports. For faster and non-invasive pain relief, it has been widely used in children with SCD and adults with chronic or cancer-related pain, and “extension of its use to adults with SCD appears to be a reasonable next step to address t…
What’s next for sickle cell disease? Key drugs to watch in 2025
Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease. The post New horizons in sickle cell disease treatment: Promising therapies on the way appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium